Top Markets
Coin of the day
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
Kedudukan dalam Saham #12786
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
Harga Saham
$5.87
Disegerakkan terakhir: 2022-11-08
Modal Pasaran
$550.43M
Perubahan (1 hari)
1.03%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Silverback Therapeutics, Inc. (SBTX)

Kategori

Harga SBTX dengan permodalan pasaran b
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
SBTX
$5.87
Modal pasaran bagi Silverback Therapeutics, Inc.(SBTX)
Modal Pasaran: $550.43M
Sehingga August 2026, Silverback Therapeutics, Inc. mempunyai modal pasaran sebanyak $550.43M. Ini menjadikan Silverback Therapeutics, Inc. syarikat ke-12786th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Silverback Therapeutics, Inc. dari 2020 hingga 2026
SBTX berbanding dengan 5 teratas yang paling popular stocks
Harga SBTX Aset B Pasaran B Hasilnya
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$56,135.85 $550.43M
$5.264T +956,217.67%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$50,136.16 $550.43M
$4.701T +854,008.32%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$44,546.98 $550.43M
$4.177T +758,792.33%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$40,710.19 $550.43M
$3.817T +693,429.61%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$30,567.68 $550.43M
$2.866T +520,644.20%